Indivumed GmbHThe Hamburg-based company Indivumed has repositioned itself, sending a clear message with a recent change in leadership: A new chapter is beginning with the focus on discovering and developing novel therapeutic targets for innovative cancer therapies. |transkript spoke with Prof. Dr. Hartmut Juhl and Dr. Matthias Evers.
Tag Archive for: Biobank
Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing therapeutics, the ultimate success of patient-data driven precision therapies hinges on three main factors: the quality of the tissue samples, the associated molecular data, and the analysis used in their development.
The Sweden Biobank Act governs the collection, storage, and usage of identifiable human material samples for specific purposes.
Jolt Capital contributed $20m to the BC Platforms’ data footprint expansion on November 8th.